Press release
20.12.2017 To the attention of interested persons Modified-release paracetamol-containing products to be suspended from EU market. download document …
Press release
20.12.2017 To the attention of interested persons EMA press release on updated recommendations for contraception in men and women taking […]
Important notification
14.12.2017 To the attention of pharmaceutical companies and interested persons The NAMMD would like to inform about the organization in […]
Press release
11.12.2017 To the attention of interested persons PRAC confirms that modified-release paracetamol should be suspended from market. download document …
Press release
11.12.2017 To the attention of interested persons EMA starts review of Esmya for uterine fibroids. download document …
Press release
11.12.2017 To the attention of interested persons Warning about use of prostate cancer medicine Xofigo in combination with Zytiga and […]
Press release
20.11.2017 To the attention of interested persons Contribute to better medicinal product safety by reporting suspected adverse drug reactions! The […]
Press release
15.11.2017 To the attention of interested persons EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of […]
Important notification
14.11.2017 To the attention of interested persons The Romanian Association of International Medicine Manufacturers (ARPIM) addresses European Medicines Agency (EMA) […]
Press release
03.11.2017 To the attention of interested persons Review of flupirtine-containing medicines started. download document …